1-6 of 6
Nico van Zandwijk
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

An immune response enriched 72-gene prognostic profile for early stage non-small-cell lung cancer (NSCLC).

Paul Roepman, Nico van Zandwijk
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (19_Supplement): PR-5.
Published: 15 August 2014
View article titled, An immune response enriched 72-gene prognostic profile for early stage non-small-cell lung cancer (NSCLC).
Journal Articles

High Blood Neutrophil-to-Lymphocyte Ratio Is an Indicator of Poor Prognosis in Malignant Mesothelioma Patients Undergoing Systemic Therapy

Steven C.H. Kao, Nick Pavlakis, Rozelle Harvie, Janette L. Vardy, Michael J. Boyer, Nico van Zandwijk, Stephen J. Clarke
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (23): 5805–5813.
https://doi.org/10.1158/1078-0432.CCR-10-2245
Published: 06 December 2010
View article titled, High Blood Neutrophil-to-Lymphocyte Ratio Is an Indicator of Poor Prognosis in Malignant Mesothelioma Patients Undergoing Systemic Therapy
Open the PDF for High Blood Neutrophil-to-Lymphocyte Ratio Is an Indicator of Poor Prognosis in Malignant Mesothelioma Patients Undergoing Systemic Therapy in another window
Journal Articles

An Immune Response Enriched 72-Gene Prognostic Profile for Early-Stage Non–Small-Cell Lung Cancer

Paul Roepman, Jacek Jassem, Egbert F. Smit, Thomas Muley, Jacek Niklinski, Tony van de Velde, Anke T. Witteveen, Witold Rzyman, Arno Floore, Sjaak Burgers, Giuseppe Giaccone, Michael Meister, Hendrik Dienemann, Marcin Skrzypski, Miroslaw Kozlowski, Wolter J. Mooi, Nico van Zandwijk
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (1): 284–290.
https://doi.org/10.1158/1078-0432.CCR-08-1258
Published: 31 December 2008
View article titled, An Immune Response Enriched 72-Gene Prognostic Profile for Early-Stage Non–Small-Cell Lung Cancer
Open the PDF for An Immune Response Enriched 72-Gene Prognostic Profile for Early-Stage Non–Small-Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Pulmonary Squamous Cell Carcinoma following Head and Neck Squamous Cell Carcinoma: Metastasis or Second Primary?

Tom W. Geurts, Petra M. Nederlof, Michiel W.M. van den Brekel, Laura J. van't Veer, Daphne de Jong, August A.M. Hart, Nico van Zandwijk, Houke Klomp, Alfons J.M. Balm, Marie-Louise F. van Velthuysen
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (18): 6608–6614.
https://doi.org/10.1158/1078-0432.CCR-05-0257
Published: 15 September 2005
View article titled, Pulmonary Squamous Cell Carcinoma following Head and Neck Squamous Cell Carcinoma: Metastasis or Second Primary?
Open the PDF for Pulmonary Squamous Cell Carcinoma following Head and Neck Squamous Cell Carcinoma: Metastasis or Second Primary? in another window
Journal Articles

Bayesian Pharmacokinetically Guided Dosing of Paclitaxel in Patients with Non-Small Cell Lung Cancer

Milly E. de Jonge, H. J. G. Desirée van den Bongard, Alwin D. R. Huitema, Ron A. A. Mathôt, Hilde Rosing, Paul Baas, Nico van Zandwijk, Jos H. Beijnen, Jan H. M. Schellens
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (7): 2237–2244.
https://doi.org/10.1158/1078-0432.CCR-03-0060
Published: 08 April 2004
View article titled, Bayesian Pharmacokinetically Guided Dosing of Paclitaxel in Patients with Non-Small Cell Lung Cancer
Open the PDF for Bayesian Pharmacokinetically Guided Dosing of Paclitaxel in Patients with Non-Small Cell Lung Cancer in another window
Journal Articles

Randomized Phase I Clinical and Pharmacologic Study of Weekly versus Twice-Weekly Dose-intensive Cisplatin and Gemcitabine in Patients with Advanced Non-Small Cell Lung Cancer

Mirjam Crul, Nadja E. Schoemaker, Dick Pluim, Marc Maliepaard, René W. M. Underberg, Margaret Schot, Rolf W. Sparidans, Paul Baas, Jos H. Beijnen, Nico van Zandwijk, Jan H. M. Schellens
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (10): 3526–3533.
Published: 23 September 2003
View article titled, Randomized Phase I Clinical and Pharmacologic Study of Weekly <em>versus</em> Twice-Weekly Dose-intensive Cisplatin and Gemcitabine in Patients with Advanced Non-Small Cell Lung Cancer
Open the PDF for Randomized Phase I Clinical and Pharmacologic Study of Weekly <em>versus</em> Twice-Weekly Dose-intensive Cisplatin and Gemcitabine in Patients with Advanced Non-Small Cell Lung Cancer in another window